HERCESSI(TM) becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...

Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of ...

Oregon's Attorney General sues insulin manufacturers and PBMs for $900 million, alleging price inflation and collusion, ...

The lawsuit alleges three manufacturers coordinated with three pharmacy benefit managers in a scheme to inflate insulin ...

A Fort Worth pharmacy went viral after revealing Medicare paid thousands for a cancer drug costing under $10, raising ...

Two Connecticut communities recently filed separate but identical federal lawsuits accusing major insulin manufacturers and ...

Clint Proctor is a lead editor with the credit cards and travel rewards team at Forbes Advisor. He has five years of experience in personal finance journalism and has contributed to a variety of ...

With close to a decade of writing and editing experience, Maisha specializes in service journalism and has produced work in the lifestyle, financial services, real estate, and culture spaces. She uses ...

The concert is scheduled for 4 p.m. Sunday at Trinity Baptist Church at 319 E. Mulberry Ave. in San Antonio.